Back
Day Range
$7.40
$7.80
52-Week Range
$2.83
$11.50
Volume
2,013,834
50D / 200D Avg
$8.62
/
$7.49
Prev Close
$7.26
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.3 | 0.4 |
| P/B | 2.6 | 2.9 |
| ROE % | -35.0 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$11.25
+47.8%
Low: $10.00
High: $13.00
Forward EPS
-$1.08
Est. Revenue
79 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.02
-$0.02 – -$0.02
|
220 M | 1 |
| FY2029 |
-$0.13
-$0.14 – -$0.12
|
180 M | 1 |
| FY2028 |
-$0.53
-$0.55 – -$0.51
|
160 M | 2 |
Key Takeaways
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -79.45M
PEG of 0.26 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-35.02%
ROIC-22.54%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.12
Current Ratio6.76
Interest Coverage-429.55
Valuation
P/E Ratio
-8.32
P/B Ratio2.59
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -81.27M |
| ROE | -35.02% | ROA | -24.32% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -79.45M |
| ROIC | -22.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 6.76 |
| Interest Coverage | -429.55 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.32 | P/B Ratio | 2.59 |
| P/S Ratio | N/A | PEG Ratio | 0.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 675.80M | Enterprise Value | 583.42M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 84.61M | 73.48M | 65.05M | 85.49M |
| Net Income | -81.27M | -81.28M | -108.30M | -113.32M | -65.23M |
| EPS (Diluted) | -0.91 | -1.37 | -2.25 | -2.48 | -1.49 |
| Gross Profit | -53.87M | 26.83M | 18.21M | 13.35M | 31.66M |
| Operating Income | -88.06M | -68.27M | -109.94M | -115.53M | -65.35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 334.16M | 270.27M | 225.10M | 292.70M | 396.53M |
| Total Liabilities | 72.98M | 67.31M | 95.66M | 74.56M | 86.23M |
| Shareholders' Equity | 261.19M | 202.96M | 129.44M | 218.14M | 310.30M |
| Total Debt | 31.87M | 44.25M | 47.73M | 48.65M | 58.33M |
| Cash & Equivalents | 124.25M | 91.42M | 56.98M | 89.13M | 105.59M |
| Current Assets | 267.95M | 203.02M | 146.74M | 199.70M | 318.23M |
| Current Liabilities | 39.63M | 31.13M | 47.23M | 33.13M | 31.31M |